Research Use Only. Reference materials for laboratory research — not for human or veterinary use.
Home / Peptides / Cagrilintide
Cagrilintide reference vial
Cagrilintide · peptide
Cagrilintide box panel
Cagrilintide vial label
Click to zoom
Metabolic signaling

Cagrilintide

$99.00 10 mg · lyophilized powder · COA per lot

Cagrilintide (long-acting amylin-receptor agonist peptide) · ≥98% (HPLC)

Cagrilintide is a synthetic 37-residue lipidated amylin-receptor agonist peptide supplied as a characterized reference material for in-vitro receptor and analytical research. For Research Use Only. Not for human or veterinary use.

More in Metabolic signaling

Tirzepatide reference vial
Limited lot
Metabolic signaling

Tirzepatide

$129.00 · 30 mg

Tirzepatide is a synthetic 39-residue lipidated dual GIP/GLP-1 receptor agonist peptide supplied as a characterized reference material for in-vitro receptor and analytical research. For Research Use Only. Not for human or veterinary use.

≥98% (HPLC) COA per lot Lot-traceable
Retatrutide reference vial
Limited lot
Metabolic signaling

Retatrutide

$179.00 · 30 mg

Retatrutide (LY3437943) is a synthetic 39-residue lipidated triple-agonist peptide used as a characterized reference material for in-vitro study of GIPR, GLP-1R, and GCGR signaling. For research use only.

≥98% (HPLC) COA per lot Lot-traceable
Semaglutide reference vial
In stock
Metabolic signaling

Semaglutide

$99.00 · 10 mg

Semaglutide is a synthetic 31-residue lipidated GLP-1 receptor agonist peptide supplied as a characterized reference material for in-vitro receptor and analytical research. For Research Use Only. Not for human or veterinary use.

≥98% (HPLC) COA per lot Lot-traceable
Full details

Research profile & documentation

Why researchers study it
Studied in receptor-pharmacology research as a long-acting amylin-analog probe engaging multiple amylin-receptor subtypes and the calcitonin receptor, often used alongside GLP-1 analogs in comparative co-agonism studies.
Mechanism themes in research
Amylin receptor (AMY1R/AMY2R/AMY3R) and calcitonin receptor (CTR) agonismPramlintide-backbone structure-activity substitutions (N14E, V17R, P37Y)C20 fatty-diacid lipidation enabling albumin association studied in PK/structural contextsComparative amylin/incretin co-agonism pharmacology
What the evidence does not establish
Published references are in-vitro or pre-clinical and describe research context only. They do not establish safety, efficacy, or any outcome in humans or animals, and Helix makes no such claims.
Quality markers
≥98% (HPLC)MS identityLot COACold-chain
What ships
The sealed lot-controlled vial, a measured ampoule of bacteriostatic water, and a printed handling & reconstitution card — plus the per-lot COA. Everything to prepare it, in one box.
Ships bench-ready Includes the sealed vial, a measured ampoule of bacteriostatic water, and a printed handling & reconstitution card — everything to prepare it, in one box. Most suppliers ship the vial alone.
Research Use Only. A reference material for in-vitro laboratory research. Not for human or veterinary use. No dosing, administration, or therapeutic guidance is provided.

Cagrilintide is a synthetic 37-residue lipidated amylin-receptor agonist peptide supplied as a characterized reference material for in-vitro receptor and analytical research. For Research Use Only. Not for human or veterinary use.

Full research overview →

Full nameCagrilintide (long-acting amylin-receptor agonist peptide)
Research themeMetabolic signaling
CAS number1415456-99-3
Molecular formulaC₁₉₄H₃₁₂N₅₄O₅₉S₂
Molecular weight4409 g/mol
Purity≥98% (HPLC)
Physical formLyophilized powder
Storage−20 °C, desiccated, protected from light

Sequence

37-residue pramlintide-backbone amylin analog (N14E, V17R, P37Y substitutions) with N-terminal acylation via a C20 eicosanedioic fatty diacid and γ-glutamic-acid linker

Reported research areas

  • Amylin receptor (AMY1R/AMY2R/AMY3R) and calcitonin receptor (CTR) agonism assays
  • Peptide lipidation and structure-activity studies
  • Comparative amylin/incretin co-agonism pharmacology
  • Analytical method development and reference standardization

Credible sources

    Listed research areas and sources reference published in-vitro and pre-clinical literature for scientific context only. They are not claims of efficacy and do not constitute medical, usage, or dosing guidance. Always verify against primary literature.

    COA with every lot

    Each Cagrilintide lot is characterized by reversed-phase HPLC for purity and by mass spectrometry for identity, then documented in a per-lot Certificate of Analysis. Unique lot numbers tie the vial back to its synthesis batch and analytical data.

    • RP-HPLC purity result (≥98% (HPLC))
    • Mass-spectrometry identity confirmation
    • Appearance, molecular weight, and storage
    • Lot number and testing status

    View Cagrilintide COA library →

    Specimen Certificate of Analysis

    ProductCagrilintide (reference)
    LotHXR-2406-111
    Purity (RP-HPLC)98%+
    Identity (MS)Confirmed · 4409 g/mol
    AppearanceLyophilized powder
    Storage−20 °C, desiccated

    Representative document. Each lot has its own COA — these are quality documents, not medical claims.

    Loading verified reviews…

    Reviews come only from buyers we can match to a real order, and each is moderated before it appears. We never publish fabricated or incentivized reviews.